Abstract
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, highly aggressive hematopoietic malignancy, characterized by cutaneous and bone marrow involvement and leukemic spread. Cutaneous involvement is the most common presentation in BPDCN. At present, the diagnosis and management of BPDCN are still challenging. Due to its rarity, the pediatric experience with BPDCN is especially limited. Herein, we report a special case of BPDCN with diffuse nodular lung metastases and a cutaneous lesion, which achieved a dramatic response to non-Hodgkin lymphoma regimen and remained with complete remission for 2 years. To date, acute lymphoblastic leukemia (ALL)-type chemotherapy followed by hematopoietic stem cell transplantation (SCT) is commonly thought to be related to a favorable outcome in adults with BPDCN. In contrast to it, ALL or non-Hodgkin lymphoma-type therapy alone seems enough in children with BPDCN with or without cutaneous lesions. SCT should only be performed for children who relapse and achieve a second remission. For pediatric BPDCN, further study of larger numbers of cases is needed to better define prognostic factors and optimal treatment strategy, and understand the underling differences in pathogenesis between children and adults.
Similar content being viewed by others
References
Adachi M, Maeda K, Takekawa M, Hinoda Y, Suqiyama S, Yachi A (1994) High expression of CD56 (N-CAM) in a patient with cutaneous CD4 positive lymphoma. Am J Hematol 47(4):278–282
An HJ, Yoon DH, Kim S, Shin SJ, Huh J, Lee KH, Suh C (2013) Blastic plasmacytoid dendritic cell neoplasm: a single-center experience. Ann Hematol 92(3):351–356
Cota C, Vale E, Viana I, Requena L, Ferrara G, Anemona L, Metze D, Fink-Puches R, Wiesner T, Cerroni L (2010) Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm- morphologic and phenotypic variability in a series of 33 patients. Am J Surg Pathol 34(1):75–87
Facchetti F, Pileri SA, Agostinelli C, Martelli MP, Paulli M, Venditti A, Martelli MF, Falini B (2009) Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm. Haematologica 94(2):285–288
Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne AS, Jaffe ES (2010) Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica 95(11):1873–1879
Lanzkowsky P (2005) Manual of Pediatric Hematology and Oncology, 4th edn. Academic, Burlington
Petrella T, Bagot M, Willemze R, Beylot-Barry M, Verqier B, Delaunay M, Meijer CJ, Courville P, Joly P, Grange F, De Muret A, Machet L, Dompmatin A, Bosq J, Durlach A, Bernard P, Dalac S, Dechelotte P, D’lincan M, Wechsler J, Teitell MA (2005) Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol 123(5):662–675
Rauh MJ, Rahman F, Good D, Silverman J, Brennan MK, Dimov N, Liesveld J, Ryan DH, Burack WR, Bennett JM (2012) Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: case series and literature review. Leuk Res 36(1):81–86
Reimer P, Rudiger T, Kraemer D, Kunzmann V, Weissinger F, Zettl A, Konrad Müller-Hermelink H, Wilhelm M (2003) What is CD4+CD56+ malignancy and how should it be treated? Bone Marrow Transplant 32(7):637–646
Shaw PH, Cohn SL, Morgan ER, Kovarik P, Haut PR, Kletzel M, Murphy SB (2001) Natural killer cell lymphoma: report of two pediatric cases, therapeutic options, and review of the literature. Cancer 91(4):642–646
Conflicts of interest
The authors indicated no potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhong, Xd., Wang, Lz., Wang, X. et al. Diffuse lung metastases in a child with blastic plasmacytoid dendritic cell neoplasm and review. Eur J Pediatr 173, 1667–1670 (2014). https://doi.org/10.1007/s00431-013-2248-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-013-2248-4